Bright Minds Biosciences DRUG
NASDAQ DRUG
$50.69 +1.48 (+3.01%)
At close: Oct 2, 2026 · 4:00 PM EDT

Bright Minds Biosciences (DRUG) Depreciation & Amortization (CF) (2022 - 2026)

Updated

Bright Minds Biosciences (DRUG) recorded Depreciation & Amortization (CF) of $14,067 in fiscal Q3 2026 (quarter ended Jun 30, 2026), up 23.0% from $11,436 a year earlier but down 2.6% from the prior quarter.

Analysis

Bright Minds Biosciences (DRUG) Depreciation & Amortization (CF) (2022 - 2026) Analysis & Trends

On a TTM basis, Bright Minds Biosciences' Depreciation & Amortization (CF) came in at $55,055 as of Jun 30, 2026, down 39.9% year-over-year; for FY2025 (ended Sep 30, 2025), it was $54,998, up 2.0% from FY2024.

  • Annual Depreciation & Amortization (CF) has a three-year compound annual growth rate of 126.6% (FY2022 to FY2025).
  • Across earlier fiscal years, Depreciation & Amortization (CF) came in at $53,932 in FY2024 (+0.4%), $53,735 in FY2023 and $4,729 in FY2022.
  • Quarterly Depreciation & Amortization (CF) has ranged from -$21,852 in fiscal Q3 2024 to $49,129 in fiscal Q4 2024 over the past five years.
  • On a year-over-year basis, Depreciation & Amortization (CF) rose in four of the last seven quarters, with growth averaging 32.6%.
  • Peak year-over-year performance for Depreciation & Amortization (CF) in the last five years was growth of 263.6% in fiscal Q4 2024, against a decline of 74.8% in fiscal Q4 2025 at the low end.
  • Per Business Quant, the preceding three fiscal quarters came in at $14,439 (Q2 2026), $14,190 (Q1 2026) and $12,359 (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 534.00 Mn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 1.96 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 194.00 Mn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 599.00 Mn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 1.93 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 1.11 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 98.00 Mn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 1.62 Bn
10 Bright Minds Biosciences 387.06 Mn 387.06 Mn - 14,066.68
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 14,066.68
Mar 31, 2026 14,439.00
Dec 31, 2025 14,190.42
Sep 30, 2025 12,359.33
Jun 30, 2025 11,435.53
Mar 31, 2025 15,667.38
Dec 31, 2024 15,414.38
Sep 30, 2024 49,128.51
Jun 30, 2024 -21,851.60
Mar 31, 2024 13,441.15
Dec 31, 2023 13,304.64
Sep 30, 2023 13,510.29
Jun 30, 2023 13,484.27
Mar 31, 2023 13,398.12
Dec 31, 2022 13,343.16
API Access

Bright Minds Biosciences Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=DRUG&period=max&api_key=YOUR_API_KEY